842 Thymidylate synthase-complementing protein Thy1
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organosulfur compounds | 1 | 0.2 | 6.16× | not tested | |
| Nucleosides, nucleotides, and analogues | 8 | 2.2 | 3.67× | not tested | |
| Benzenoids | 1 | 0.6 | 1.73× | not tested | |
| Homogeneous non-metal compounds | 2 | 1.7 | 1.18× | not tested | |
| Organoheterocyclic compounds | 1 | 1.2 | 0.82× | not tested | |
| Organic acids and derivatives | 1 | 1.2 | 0.82× | not tested | |
| Homogeneous metal compounds | 1 | 3.9 | 0.26× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03147 | FAD | Flavin adenine dinucleotide | 141 |
| DB03800 | UMP | Deoxyuridine monophosphate | 58 |
| DB01903 | BRU | 5-Bromo-2'-deoxyuridine 5'-(dihydrogen phosphate) | 16 |
| DB03761 | UFP | 5-fluoro-2'-deoxyuridine-5'-monophosphate | 16 |
| DB12676 | MEF | Modufolin | 6 |
| DB02256 | DUR | 2'-Deoxyuridine | 4 |
| DB03461 | NAP | Nicotinamide adenine dinucleotide phosphate | 4 |
| DB00140 | RBF | Riboflavin | 1 |
| DB00293 | D16 | Raltitrexed | 1 |
| DB11596 | FFO | Levoleucovorin | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| FAD | FLAVIN-ADENINE DINUCLEOTIDE | 145 |
| UMP | 2'-DEOXYURIDINE 5'-MONOPHOSPHATE | 54 |
| FDA | DIHYDROFLAVINE-ADENINE DINUCLEOTIDE | 23 |
| 0VJ | 2-hydroxy-3-(4-methoxybenzyl)naphthalene-1,4-dione | 16 |
| UFP | 5-FLUORO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE | 16 |
| IOD | IODIDE ION | 10 |
| BRU | 5-BROMO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE | 8 |
| DU | 2'-DEOXYURIDINE-5'-MONOPHOSPHATE | 8 |
| HUF | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2R,3S,4S)-5-[5-methanoyl-7,8-dimethyl-2,4-bis(oxidanylidene)-1H-benzo[g]pteridin-10-yl]-2,3,4-tris(oxidanyl)pentyl] hydrogen phosphate | 8 |
| MEF | N-({4-[(6aR)-3-amino-1-oxo-1,2,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9H)-yl]phenyl}carbonyl)-L-glutamic acid | 6 |
| CL | CHLORIDE ION | 5 |
| 5BU | 5-BROMO-URIDINE-5'-MONOPHOSPHATE | 4 |
| DUR | 2'-DEOXYURIDINE | 4 |
| Kmetal | POTASSIUM ION | 4 |
| NAP | NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 4 |
| PG6 | 1-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]-ETHOXY}-ETHANE | 3 |
| P6G | HEXAETHYLENE GLYCOL | 2 |
| DUS | 2'-deoxy-5'-O-sulfouridine | 1 |
| FFO | N-[4-({[(6S)-2-amino-5-formyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid | 1 |
| UMC | 2'-deoxy-5'-uridylic acid | 1 |